178 related articles for article (PubMed ID: 12194700)
1. Polycystic kidney disease in patients on the renal transplant waiting list: trends in hematocrit and survival.
Abbott KC; Agodoa LY
BMC Nephrol; 2002 Aug; 3():7. PubMed ID: 12194700
[TBL] [Abstract][Full Text] [Related]
2. Polycystic kidney disease at end-stage renal disease in the United States: patient characteristics and survival.
Abbott KC; Agodoa LY
Clin Nephrol; 2002 Mar; 57(3):208-14. PubMed ID: 11924752
[TBL] [Abstract][Full Text] [Related]
3. Hospitalizations for bacterial septicemia in patients with end stage renal disease due to diabetes on the renal transplant waiting list.
Abbott KC; Napier MG; Agodoa LY
J Nephrol; 2002; 15(3):248-54. PubMed ID: 12113595
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness of Peritoneal Dialysis in Treating Adult End Stage Renal Disease Patients with Polycystic Kidney Disease.
Ma Y; Wang HY; Zhou ZJ; Li Y; Yang W; Liu BY; Xia JH; Li XM; Chen LM
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2017 Aug; 39(4):485-491. PubMed ID: 28877825
[TBL] [Abstract][Full Text] [Related]
5. Impact of renal transplantation on survival in end-stage renal disease patients with elevated body mass index.
Glanton CW; Kao TC; Cruess D; Agodoa LY; Abbott KC
Kidney Int; 2003 Feb; 63(2):647-53. PubMed ID: 12631130
[TBL] [Abstract][Full Text] [Related]
6. Incidence and survival of end-stage kidney disease due to polycystic kidney disease in Australia and New Zealand (1963-2014).
Fernando MR; Dent H; McDonald SP; Rangan GK
Popul Health Metr; 2017 Feb; 15(1):7. PubMed ID: 28212688
[TBL] [Abstract][Full Text] [Related]
7. Body mass index and enrollment on the renal transplant waiting list in the United States.
Abbott KC; Glanton CW; Agodoa LY
J Nephrol; 2003; 16(1):40-8. PubMed ID: 12649534
[TBL] [Abstract][Full Text] [Related]
8. Sickle cell nephropathy at end-stage renal disease in the United States: patient characteristics and survival.
Abbott KC; Hypolite IO; Agodoa LY
Clin Nephrol; 2002 Jul; 58(1):9-15. PubMed ID: 12141416
[TBL] [Abstract][Full Text] [Related]
9. Is Peritoneal Dialysis a Suitable Renal Replacement Therapy Option for Polycystic Kidney Disease Patients?
Zhang T; Dou Y; Wang X; Li J; Cao S
Kidney Blood Press Res; 2018; 43(5):1539-1553. PubMed ID: 30286463
[TBL] [Abstract][Full Text] [Related]
10. Duration of end-stage renal disease and kidney transplant outcome.
Goldfarb-Rumyantzev A; Hurdle JF; Scandling J; Wang Z; Baird B; Barenbaum L; Cheung AK
Nephrol Dial Transplant; 2005 Jan; 20(1):167-75. PubMed ID: 15546892
[TBL] [Abstract][Full Text] [Related]
11. [REIN Report 2011--summary].
Couchoud C; Lassalle M; Jacquelinet C
Nephrol Ther; 2013 Sep; 9 Suppl 1():S3-6. PubMed ID: 24119584
[TBL] [Abstract][Full Text] [Related]
12. Association between attributed cause of end-stage renal disease and risk of death in Brazilian patients receiving renal replacement therapy.
Batista PB; Lopes AA; Costa FA
Ren Fail; 2005; 27(6):651-6. PubMed ID: 16350813
[TBL] [Abstract][Full Text] [Related]
13. Comparison of mortality risk for dialysis patients and cadaveric first renal transplant recipients in Ontario, Canada.
Rabbat CG; Thorpe KE; Russell JD; Churchill DN
J Am Soc Nephrol; 2000 May; 11(5):917-922. PubMed ID: 10770970
[TBL] [Abstract][Full Text] [Related]
14. Is peritoneal dialysis a therapeutic option for polycystic kidney disease? 15 years' experience in a single center.
Koc Y; Basturk T; Sakaci T; Atan Ucar Z; Ahbap E; Sevinc M; Sinangil A; Kara E; Ozdemir Kayalar A; Bayraktar Caglayan F; Sahutoglu T; Baris Hasbal N; Ünsal A
Nephrol Ther; 2016 Jul; 12(4):215-20. PubMed ID: 27320369
[TBL] [Abstract][Full Text] [Related]
15. Improved survival rate in patients with diabetes and end-stage renal disease in Denmark.
Sørensen VR; Mathiesen ER; Heaf J; Feldt-Rasmussen B
Diabetologia; 2007 May; 50(5):922-9. PubMed ID: 17333109
[TBL] [Abstract][Full Text] [Related]
16. Peritoneal dialysis in polycystic kidney disease patients. Report from the French peritoneal dialysis registry (RDPLF).
Lobbedez T; Touam M; Evans D; Ryckelynck JP; Knebelman B; Verger C
Nephrol Dial Transplant; 2011 Jul; 26(7):2332-9. PubMed ID: 21115669
[TBL] [Abstract][Full Text] [Related]
17. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant.
Wolfe RA; Ashby VB; Milford EL; Ojo AO; Ettenger RE; Agodoa LY; Held PJ; Port FK
N Engl J Med; 1999 Dec; 341(23):1725-30. PubMed ID: 10580071
[TBL] [Abstract][Full Text] [Related]
18. Effect of the ownership of dialysis facilities on patients' survival and referral for transplantation.
Garg PP; Frick KD; Diener-West M; Powe NR
N Engl J Med; 1999 Nov; 341(22):1653-60. PubMed ID: 10572154
[TBL] [Abstract][Full Text] [Related]
19. Comparison of quality-of-care measures in U.S. patients with end-stage renal disease secondary to lupus nephritis vs. other causes.
Plantinga LC; Patzer RE; Drenkard C; Pastan SO; Cobb J; McClellan W; Lim SS
BMC Nephrol; 2015 Mar; 16():39. PubMed ID: 25884409
[TBL] [Abstract][Full Text] [Related]
20. Functional status, time to transplantation, and survival benefit of kidney transplantation among wait-listed candidates.
Reese PP; Shults J; Bloom RD; Mussell A; Harhay MN; Abt P; Levine M; Johansen KL; Karlawish JT; Feldman HI
Am J Kidney Dis; 2015 Nov; 66(5):837-45. PubMed ID: 26162652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
